The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface.
نویسندگان
چکیده
منابع مشابه
Colonoscopic Findings and Histological Changes in Patients Suffering from Ankylosing Spondylitis with Normal Bowel Habit
Ankylosing Spondylitis is a form of spondyloarthropathies characterized by chronic inflammation of the joints of axial skeleton, manifested clinically by pain and progressive stiffening of spine. It is evidenced that sero-negative spondyloarthropathies are closely related with gut inflammatory lesions. This inflammatory gut lesions may be clinically silent or with abnormal bowel symptoms. This ...
متن کاملDiagnostic imaging of sacroiliac joints and the spine in the course of spondyloarthropathies
Spondyloarthropathies belong to a group of rheumatic diseases, in which inflammatory changes affect mainly the sacroiliac joints, spine, peripheral joints, tendon, ligaments and capsule attachments (entheses). This group includes 6 entities: ankylosing spondylitis, arthritis associated with inflammatory bowel disease, reactive arthritis, undifferentiated spondyloarthropathy, psoriatic arthritis...
متن کاملUrolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI)
Background: Increased incidence of renal stone has been reported in ankylosing spondylitis (AS), but unlike some well-known renal involvements, they have not been fully studied. The aim of this study was to investigate the association of AS with urolithiasis and also the relation between urinary stone and severity markers. Methods: One hundred-sixty three AS patients were included in a cross-s...
متن کاملIL-17 Blockade in Psoriasis
IL-17A both directly induces and synergizes with other cytokines to promote autoimmune tissue inflammation. Secukinumab and ixekizumab are monoclonal antibodies (mAb) that inhibit interleukin-17A. These two agents were recently approved for treatment of psoriasis, and secukinumab is also approved for treatment of two spondyloarthropathies, psoriatic arthritis and ankylosing spondylitis.
متن کاملManagement of Seronegative Spondyloarthropathies
The spondyloarthropathies are a group of rheumatic disorders that include ankylosing spondylitis (AS), reactive arthritis, psoriatic arthritis and enteropathic arthritis. These disorders are unified in their ability to manifest axial and/or peripheral inflammatory disease with the associated features of enthesitis, ocular inflammation, skin and nail changes, and mucosal lesions affecting the ga...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of rheumatology
دوره 30 11 شماره
صفحات -
تاریخ انتشار 2003